Zobrazeno 1 - 10
of 125
pro vyhledávání: '"Karsten, Nysom"'
Autor:
Sierra Alef-Defoe, Solenne Carof, Nanna Maria Hammer, Sylvain Besle, Hanne Baekgaard Larsen, Britt Pinkowski Tersbøl, Karsten Nysom
Publikováno v:
EJC Paediatric Oncology, Vol 4, Iss , Pp 100188- (2024)
Introduction: As 15 % of childhood cancers are still incurable, early phase clinical trials are essential in developing better therapies for children with cancer. Accessing relevant trials can be challenging, exacerbated by increasingly specialized t
Externí odkaz:
https://doaj.org/article/658750bfc9b843af9530e98109393213
Autor:
Jelena Rascon, Renata Blackute, Alma Cerkauskiene, Sabine Taschner-Mandl, Nuno Andrade, Adriana Planinic, Stefan Rutkowski, Ulrich Schuller, Karsten Nysom, Ruta Tuckuviene, Jesper Brok, Kjeld Schmiegelow, Marry M. van den Heuvel-Eibrink, M.E. Madeleine van der Perk, Riccardo Haupt, Monica Muraca, Davide Saraceno, Birgit Geoerger, Giorgia Manuzi, Ruth Ladenstein
Publikováno v:
EJC Paediatric Oncology, Vol 3, Iss , Pp 100153- (2024)
Inequalities in research and innovations affect childhood cancer survival across Europe. Vilnius University Hospital Santaros Klinikos (VULSK, the coordinator) and eight research-intensive institutions from seven European countries implemented the TR
Externí odkaz:
https://doaj.org/article/60514195038c4ebba5a83f379381f1cc
Autor:
André Baruchel, Yves Bertrand, Karsten Nysom, Hyoung Jin Kang, Monica Makiya, Jonas Abrahamsson, Oscar González-Llano, Willy Quinones Choque, Carmelo Rizzari, Jochen Buechner, Simone Cesaro, Ximo Duarte, Franca Fagioli, Antonis Kattamis, Guy Leverger, Brigitte Nelken, Lynn Wang, Sandrine Mace, Corina Oprea, Giovanni Abbadessa, Michel Zwaan
Publikováno v:
HemaSphere, Vol 7, p e121813e (2023)
Externí odkaz:
https://doaj.org/article/f5ec1f4fac334a589380dfa11828ba09
Autor:
Jaume Mora, Godfrey C. Chan, Daniel A. Morgenstern, Karsten Nysom, Melissa K. Bear, Karen Tornøe, Brian H. Kushner
Publikováno v:
Cancer Reports, Vol 6, Iss 1, Pp n/a-n/a (2023)
Abstract Background Naxitamab is a humanized GD2‐binding monoclonal antibody that received accelerated approval from the U.S. Food and Drug Administration for refractory or relapsed high‐risk neuroblastoma limited to bone or bone marrow. Trial 20
Externí odkaz:
https://doaj.org/article/75154eee605545ceb3d10714c295ce08
Autor:
Daniel Gram, André Haraldsson, N. Patrik Brodin, Karsten Nysom, Thomas Björk-Eriksson, Per Munck af Rosenschöld
Publikováno v:
Radiation Oncology, Vol 15, Iss 1, Pp 1-11 (2020)
Abstract Background Optimal alignment is of utmost importance when treating pediatric patients with craniospinal irradiation (CSI), especially with regards to field junctions and multiple isocenters and techniques applying high dose gradients. Here,
Externí odkaz:
https://doaj.org/article/9907974ee6524ae1b855669b76a6e89a
Autor:
Inge M. van der Sluis, Paola de Lorenzo, Rishi S. Kotecha, Andishe Attarbaschi, Gabriele Escherich, Karsten Nysom, Jan Stary, Alina Ferster, Benoit Brethon, Franco Locatelli, Martin Schrappe, Peggy E. Scholte-van Houtem, Maria G. Valsecchi, Rob Pieters
Publikováno v:
New England Journal of Medicine. 388:1572-1581
Autor:
Andrew DJ. Pearson, Carl Allen, Jason Fangusaro, Caroline Hutter, Olaf Witt, Susan Weiner, Gregory Reaman, Mark Russo, Pratiti Bandopadhayay, Sama Ahsan, Amy Barone, Elly Barry, Teresa de Rojas, Michael Fisher, Elizabeth Fox, Julia Glade Bender, Lia Gore, Darren Hargrave, Doug Hawkins, Brent Kreider, Abraham J. Langseth, Giovanni Lesa, Franca Ligas, Marcelo Marotti, Lynley V. Marshall, Kahina Nasri, Koen Norga, Karsten Nysom, Alberto Pappo, Gianluca Rossato, Nicole Scobie, Malcolm Smith, Elliot Stieglitz, Brenda Weigel, Amy Weinstein, Ruth Viana, Dominik Karres, Gilles Vassal
Publikováno v:
European Journal of Cancer. 177:120-142
Autor:
Birgit Geoerger, Lynley V. Marshall, Karsten Nysom, Guy Makin, Eric Bouffet, Anne-Sophie Defachelles, Loredana Amoroso, Isabelle Aerts, Pierre Leblond, Paulette Barahona, Kim Van-Vlerken, Eric Fu, Flavio Solca, Robert M. Lorence, David S. Ziegler
Publikováno v:
Geoerger, B, Marshall, L V, Nysom, K, Makin, G, Bouffet, E, Defachelles, A, Amoroso, L, Aerts, I, Leblond, P, Barahona, P, Van-Vlerken, K, Fu, E, Solca, F, Lorence, R M & Ziegler, D S 2023, ' Afatinib in paediatric patients with recurrent/refractory ErbB-dysregulated tumours: Results of a phase I/expansion trial ', European Journal of Cancer, vol. 188, pp. 8-19 . https://doi.org/10.1016/j.ejca.2023.04.007
AimThis phase I/expansion study assessed the safety, pharmacokinetics and preliminary antitumor activity of afatinib in paediatric patients with cancer.MethodsThe dose-finding part enroled patients (2–150); HER2 membrane staining (H-score>0). The p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84e7ec8128779224aaf622e0bc13f9e5
https://research.manchester.ac.uk/en/publications/dd144159-5cb1-4625-acc3-ccddb47135db
https://research.manchester.ac.uk/en/publications/dd144159-5cb1-4625-acc3-ccddb47135db
Autor:
Lucas Moreno, Steven G. DuBois, Julia Glade Bender, Audrey Mauguen, Nick Bird, Vickie Buenger, Michela Casanova, François Doz, Elizabeth Fox, Lia Gore, Douglas S. Hawkins, Shai Izraeli, David T.W. Jones, Pamela R. Kearns, Jan J. Molenaar, Karsten Nysom, Stefan Pfister, Gregory Reaman, Malcolm Smith, Brenda Weigel, Gilles Vassal, Christian Michel Zwaan, Xavier Paoletti, Alexia Iasonos, Andrew D.J. Pearson
Publikováno v:
Scientia
PURPOSE There is an increasing need to evaluate innovative drugs for childhood cancer using combination strategies. Strong biological rationale and clinical experience suggest that multiple agents will be more efficacious than monotherapy for most di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42cfed0b001a0a7bb4dbc82e8b4ec2a0
https://hdl.handle.net/11351/9922
https://hdl.handle.net/11351/9922
Autor:
Morten Wibroe, Johan Cappelen, Charlotte Castor, Niels Clausen, Pernilla Grillner, Thora Gudrunardottir, Ramneek Gupta, Bengt Gustavsson, Mats Heyman, Stefan Holm, Atte Karppinen, Camilla Klausen, Tuula Lönnqvist, René Mathiasen, Pelle Nilsson, Karsten Nysom, Karin Persson, Olof Rask, Kjeld Schmiegelow, Astrid Sehested, Harald Thomassen, Ingrid Tonning-Olsson, Barbara Zetterqvist, Marianne Juhler
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-7 (2017)
Abstract Background Central nervous system tumours constitute 25% of all childhood cancers; more than half are located in the posterior fossa and surgery is usually part of therapy. One of the most disabling late effects of posterior fossa tumour sur
Externí odkaz:
https://doaj.org/article/3e8c4631c2c34fc9b9960228cbb57460